ARA-290, also known as cibinetide, is a synthetic peptide derivative of erythropoietin (EPO) designed to selectively target the innate repair receptor (IRR) without activating the erythropoietic pathway. Structurally, it is an 11–amino acid peptide modeled from the B-helix region of EPO, engineered to retain tissue-protective properties while avoiding stimulation of red blood cell production.
In research contexts, ARA-290 is studied for its interaction with the
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption.
Laboratory research purposes only and are not intended for human consumption.
Third-party lab results for this product. Click to enlarge.
Handling and safety information for this product. Click to view the full document.
Open Safety Data Sheet (PDF) in a new tab